tx 3301 has been researched along with Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V | 1 |
Bergmann, SR | 1 |
1 trial(s) available for tx 3301 and Ischemia
Article | Year |
---|---|
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Erythrocytes; Female; Humans; Ischemia; Leukocytes; Male; Middle Aged; Risk Factors; Spectrometry, Fluorescence; Stroke; Time Factors; Treatment Outcome | 2009 |
1 other study(ies) available for tx 3301 and Ischemia
Article | Year |
---|---|
Aggrenox and stress testing.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemia; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents | 2001 |